3-hydroxy gepirone for the treatment of attention deficit...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/506 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2720133

The present invention relates to a method for alleviation, prevention, and treatment of attention deficit disorder, sexual dysfunction, and related conditions by administering certain bioactive metabolites of the known anti-depressant compound gepirone. In a preferred embodiment, the compound is 4,4,-dimethyl-3-hydroxy-1- [4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,6- piperidinedione (3-OH gepirone).

La présente invention concerne un procédé pour le soulagement, la prévention et le traitement du trouble déficitaire de lattention, de dysfonctionnement sexuel et détats associés par ladministration de certains métabolites bioactifs du composé antidépresseur connu sous le nom de gépirone. Dans un mode de réalisation préféré, le composé est la 4,4,-diméthyl-3-hydroxy-1-[4-[4-(2-pyrimidinyl)-1-pipérazinyl]butyl]-2,6-pipéridinedione (3-OH gépirone).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

3-hydroxy gepirone for the treatment of attention deficit... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-hydroxy gepirone for the treatment of attention deficit..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-hydroxy gepirone for the treatment of attention deficit... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2065319

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.